GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedencare AB (OTCPK:SWDCF) » Definitions » YoY EBITDA Growth

SWDCF (Swedencare AB) YoY EBITDA Growth : -1.23% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Swedencare AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Swedencare AB's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was -1.23%.

Swedencare AB's EBITDA per Share for the three months ended in Mar. 2025 was $0.08.


Swedencare AB YoY EBITDA Growth Historical Data

The historical data trend for Swedencare AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swedencare AB YoY EBITDA Growth Chart

Swedencare AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.74 78.95 77.94 22.73 6.06

Swedencare AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.57 29.23 5.13 -2.41 -1.23

Swedencare AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Swedencare AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.315-0.297)/ | 0.297 |
=6.06 %

Swedencare AB's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (Q: Mar. 2025 )
=(EBITDA per Share (Q: Mar. 2025 )-EBITDA per Share (Q: Mar. 2024 )) / | EBITDA per Share (Q: Mar. 2024 )) |
=(0.08-0.081)/ | 0.081 |
=-1.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Swedencare AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Swedencare AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Swedencare AB Business Description

Traded in Other Exchanges
Address
Per Albin Hanssons Vag 41, Medeon Science Park, Malmo, SWE, 205 12
Swedencare AB specializes in pet healthcare. It develops, manufactures partly in its factories, markets, and sells products in the fast-growing market of healthcare products for cats, dogs, and horses. The group has an extensive portfolio of brands and products in various therapy areas, including Animal Pharmaceuticals, Nutravet, NutriScience, Pet MD, Stratford, VetWELL, ProDen PlaqueOff, Rx Vitamins, Riley's, NaturVet, Pet Organics, Overby Farm, Vet Classics, and Innovet's brands. Its products are sold to veterinarians, pet stores, and online through a distribution network comprising various subsidiaries and an international network of retailers. The group's operating segments include North America, which generates maximum revenue, Europe, and Production.

Swedencare AB Headlines